IPO Monitor

China Nuokang Prices Initial Public Offering (IPO)

Posted in Uncategorized by J. Scotty on December 10, 2009

China Nuokang Bio-Pharmaceutical Inc. priced 4.5 million ADSs early today in their U.S. IPO.  Selling shareholders sold an additional half-million ADSs.

China Nuokang is a profitable China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products.

The ADSs are expected to trade on the NASDAQ under the symbol NKBP.

Subscribers can read more via the China Nuokang company profile page.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: